Absolute Investment Advisers’s abrdn Life Sciences Investors HQL Stock Holding History

Absolute Investment Advisers’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$582K	Buy	+35,755	New	+$598K	0.07%	113
2025 Q2	–	Sell	-192,378	Closed	-$2.44M	–	121
2025 Q1	$2.44M	Sell	192,378 -207,148	-52%	-$2.81M	0.36%	79
2024 Q4	$5.24M	Sell	399,526 -141,877	-26%	-$2.05M	0.67%	72
2024 Q3	$8.16M	Sell	541,403 -21,816	-4%	-$330K	1.11%	39
2024 Q2	$7.98M	Sell	563,219 -35,189	-6%	-$476K	1.18%	39
2024 Q1	$8.16M	Buy	+598,408	New	+$8.28M	1.11%	41

Other funds holding HQL

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Absolute Investment Advisers's HQL Position: Q1 2026 in Review

Absolute Investment Advisers opened a new position in abrdn Life Sciences Investors (HQL) in Q1 2026: 35,755 shares worth $582K. The stake represents 0.07% of the portfolio and ranks #113 among its holdings. This is a return to the name: Absolute Investment Advisers previously reported a position in HQL as recently as Q1 2025.

Absolute Investment Advisers first reported a position in HQL in Q1 2024 and has held it in 6 quarters since. The position peaked at $8.16M in Q3 2024. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

Absolute Investment Advisers held 35,755 shares of abrdn Life Sciences Investors worth $582K as of Q1 2026.
abrdn Life Sciences Investors was a new Absolute Investment Advisers position in Q1 2026.
abrdn Life Sciences Investors made up 0.07% of Absolute Investment Advisers's portfolio in Q1 2026, its #113 holding.
Absolute Investment Advisers first reported a position in abrdn Life Sciences Investors in Q1 2024 and has held it in 6 quarters since.
Absolute Investment Advisers's abrdn Life Sciences Investors position peaked at $8.16M in Q3 2024.
86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Absolute Investment Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.